Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAPATINIB Cause Metastases to central nervous system? 160 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Metastases to central nervous system have been filed in association with LAPATINIB. This represents 8.1% of all adverse event reports for LAPATINIB.

160
Reports of Metastases to central nervous system with LAPATINIB
8.1%
of all LAPATINIB reports
32
Deaths
32
Hospitalizations

How Dangerous Is Metastases to central nervous system From LAPATINIB?

Of the 160 reports, 32 (20.0%) resulted in death, 32 (20.0%) required hospitalization, and 1 (0.6%) were considered life-threatening.

Is Metastases to central nervous system Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAPATINIB. However, 160 reports have been filed with the FAERS database.

What Other Side Effects Does LAPATINIB Cause?

Diarrhoea (382) Disease progression (227) Palmar-plantar erythrodysaesthesia syndrome (182) Malignant neoplasm progression (173) Nausea (161) Neutropenia (160) Vomiting (155) Asthenia (148) Fatigue (139) Off label use (118)

What Other Drugs Cause Metastases to central nervous system?

TRASTUZUMAB (1,180) CAPECITABINE (663) OSIMERTINIB (560) PERTUZUMAB (540) PACLITAXEL (498) NIVOLUMAB (495) DABRAFENIB (451) CARBOPLATIN (413) DOCETAXEL (410) ADO-TRASTUZUMAB EMTANSINE (386)

Which LAPATINIB Alternatives Have Lower Metastases to central nervous system Risk?

LAPATINIB vs LAPATINIB DITOSYLATE LAPATINIB vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN LAPATINIB vs LARONIDASE LAPATINIB vs LAROTRECTINIB LAPATINIB vs LASILIX

Related Pages

LAPATINIB Full Profile All Metastases to central nervous system Reports All Drugs Causing Metastases to central nervous system LAPATINIB Demographics